Two new anti-viral pills have been shown to be safe and effective against COVID in clinical trials, according to recent press releases. The drugs, molnupiravir, developed by Merck and Ridgeback Biotherapeutics, and Paxlovid, developed by Pfizer both appear to significantly reduce hospitalisation in people with early COVID. Some researchers are quietly hopeful that these new weapons in the anti-COVID arsenal could have a big impact, in particular in parts of the world where vaccines are still not widely available, but there are a number of caveats. In this episode of Coronapod, we open the pill boxes and pick through the contents - asking how the drugs work, what side effects we might see and how, if at all, they might change the course of the pandemic.
News: COVID antiviral pills: what scientists still want to know
Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
See acast.com/privacy for privacy and opt-out information.
Alphafold 3.0: the AI protein predictor gets an upgrade
Talking about sex and gender doesn't need to be toxic
Dad's microbiome can affect offsprings' health — in mice
Audio long read: Why loneliness is bad for your health
How gliding marsupials got their 'wings'
Living on Mars would probably suck — here's why
Keys, wallet, phone: the neuroscience behind working memory
The 'ghost roads' driving tropical deforestation
Audio long read: Why are so many young people getting cancer? What the data say
Pregnancy's effect on 'biological' age, polite birds, and the carbon cost of home-grown veg
How climate change is affecting global timekeeping
AI hears hidden X factor in zebra finch love songs
Killer whales have menopause. Now scientists think they know why
These tiny fish combine electric pulses to probe the environment
Could this one-time ‘epigenetic’ treatment control cholesterol?
Audio long read: Chimpanzees are dying from our colds — these scientists are trying to save them
How whales sing without drowning, an anatomical mystery solved
Why are we nice? Altruism's origins are put to the test
Smoking changes your immune system, even years after quitting
Why we need to rethink how we talk about cancer
Create your
podcast in
minutes
It is Free
Economist Podcasts
NPP BrainPod
Pediatric Research Podcast
Eye Podcast